Pfizer's Covid-19 booster preferred due to higher effectiveness, says MOH
Published: Nov 12, 2021 12:30 PM | Updated: Nov 12, 2021 4:08 PM
• UPDATED 12.05AM | Added more context on heterologous vaccinations in Thailand.
The Health Ministry has defended its decision to endorse the Covid-19 vaccine from Pfizer-BioNTech as the preferred vaccine for administering booster shots to people who previously received the Sinovac vaccine.
Moreover, it also unveiled a proposed plan that would see most vaccine recipients eventually get a Pfizer booster once given the green light by the National Pharmaceutical Regulatory Agency (NPRA).
Nevertheless, it will still be possible for...
View Comments0
Report this comment
500 characters remaining






Are you sure you want to delete this comment?
This action cannot be undone.